SMN1 and proximal spinal muscular atrophy: In order to develop a therapeutic cure for SMA, complementary SMN-dependent and -independent treatment strategies are necessary to address all aspects of SMA pathology to improve quality of life across the lifespan of SMA-affected individuals.